A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Trial Profile

A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs NTRA 2112 (Primary)
  • Indications Gastrointestinal disorders; Nutrition disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Nutrinia
  • Most Recent Events

    • 03 Nov 2016 According to Nutrinia media release, Professor Hans van Goudoever of The Academic Medical Center in Amsterdam is the chief principal investigator of this study.
    • 03 Nov 2016 According to Nutrinia media release, company announced the enrollment of the first patient in this study.
    • 21 Oct 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top